These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 32386920)
21. Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates. Cooper ZD; Evans SM; Foltin RW Exp Clin Psychopharmacol; 2021 Apr; 29(2):137-146. PubMed ID: 34043398 [TBL] [Abstract][Full Text] [Related]
22. Transgenerational attenuation of opioid self-administration as a consequence of adolescent morphine exposure. Vassoler FM; Oliver DJ; Wyse C; Blau A; Shtutman M; Turner JR; Byrnes EM Neuropharmacology; 2017 Feb; 113(Pt A):271-280. PubMed ID: 27729240 [TBL] [Abstract][Full Text] [Related]
23. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615 [TBL] [Abstract][Full Text] [Related]
24. Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress. Spanagel R; Sillaber I; Zieglgänsberger W; Corrigall WA; Stewart J; Shaham Y Psychopharmacology (Berl); 1998 Oct; 139(4):391-401. PubMed ID: 9809860 [TBL] [Abstract][Full Text] [Related]
25. Maternal exposure to low doses of delta9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring. Rubio P; Rodríguez de Fonseca F; Martín-Calderón JL; Del Arco I; Bartolomé S; Villanúa MA; Navarro M Pharmacol Biochem Behav; 1998 Nov; 61(3):229-38. PubMed ID: 9768557 [TBL] [Abstract][Full Text] [Related]
26. Δ Moore CF; Davis CM; Sempio C; Klawitter J; Christians U; Weerts EM Cannabis Cannabinoid Res; 2024 Feb; 9(1):111-120. PubMed ID: 36179013 [No Abstract] [Full Text] [Related]
27. Cross-generational THC exposure alters the developmental sensitivity of ventral and dorsal striatal gene expression in male and female offspring. Szutorisz H; Egervári G; Sperry J; Carter JM; Hurd YL Neurotoxicol Teratol; 2016; 58():107-114. PubMed ID: 27221226 [TBL] [Abstract][Full Text] [Related]
28. Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy. Cannella N; Lunerti V; Shen Q; Li H; Benvenuti F; Soverchia L; Narendran R; Weiss F; Ciccocioppo R Neuropharmacology; 2024 Oct; 257():110048. PubMed ID: 38901642 [TBL] [Abstract][Full Text] [Related]
29. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602 [TBL] [Abstract][Full Text] [Related]
30. Dosage choices of rats for morphine, for heroin, and between morphine and heroin. Hutto CW; Crowder WF Pharmacol Biochem Behav; 1997 Sep; 58(1):133-40. PubMed ID: 9264081 [TBL] [Abstract][Full Text] [Related]
31. Effects of prior cocaine versus morphine or heroin self-administration on extinction learning driven by overexpectation versus omission of reward. Lucantonio F; Kambhampati S; Haney RZ; Atalayer D; Rowland NE; Shaham Y; Schoenbaum G Biol Psychiatry; 2015 May; 77(10):912-20. PubMed ID: 25641634 [TBL] [Abstract][Full Text] [Related]
32. Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats. Manwell LA; Mallet PE Psychopharmacology (Berl); 2015 May; 232(9):1655-65. PubMed ID: 25395060 [TBL] [Abstract][Full Text] [Related]
33. Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction. Lamarque S; Taghzouti K; Simon H Neuropharmacology; 2001 Jul; 41(1):118-29. PubMed ID: 11445192 [TBL] [Abstract][Full Text] [Related]
34. Attenuated effects of experimenter-administered heroin in adolescent vs. adult male rats: physical withdrawal and locomotor sensitization. Doherty JM; Frantz KJ Psychopharmacology (Berl); 2013 Feb; 225(3):595-604. PubMed ID: 22941050 [TBL] [Abstract][Full Text] [Related]
35. Intravenous cocaine and heroin self-administration in rats selectively bred for differential saccharin intake: phenotype and sex differences. Carroll ME; Morgan AD; Lynch WJ; Campbell UC; Dess NK Psychopharmacology (Berl); 2002 May; 161(3):304-13. PubMed ID: 12021834 [TBL] [Abstract][Full Text] [Related]
36. Decrease of cocaine, but not heroin, self-administration and relapse by the tyrosine kinase inhibitor masitinib in male Sprague Dawley rats. Belin-Rauscent A; Lacoste J; Hermine O; Moussy A; Everitt BJ; Belin D Psychopharmacology (Berl); 2018 May; 235(5):1545-1556. PubMed ID: 29520592 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of reinforcing and aversive effects of voluntary Δ Barrus DG; Lefever TW; Wiley JL Neuropharmacology; 2018 Jul; 137():133-140. PubMed ID: 29758385 [TBL] [Abstract][Full Text] [Related]
38. Locomotor activity does not predict individual differences in morphine self-administration in rats. Swain Y; Muelken P; LeSage MG; Gewirtz JC; Harris AC Pharmacol Biochem Behav; 2018 Mar; 166():48-56. PubMed ID: 29409807 [TBL] [Abstract][Full Text] [Related]
39. Paternal morphine exposure induces bidirectional effects on cocaine versus opioid self-administration. Vassoler FM; Toorie AM; Teceno DN; Walia P; Moore DJ; Patton TD; Byrnes EM Neuropharmacology; 2020 Jan; 162():107852. PubMed ID: 31726075 [TBL] [Abstract][Full Text] [Related]
40. Persisting neurobehavioral consequences of daily or intermittent paternal cannabis administration in F1 and F2 Rats. Hawkey AB; Natarajan S; Kelly O; Gondal A; Wells C; Jones ML; Rezvani AH; Murphy SK; Levin ED Neurotoxicology; 2024 Jul; 103():27-38. PubMed ID: 38810733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]